PNC Financial Services Group’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-826
Closed -$2.6K – 5151
2025
Q3
$2.6K Sell
826
-3,157
-79% -$8.66K ﹤0.01% 4428
2025
Q2
$9K Buy
3,983
+2,204
+124% +$6.28K ﹤0.01% 3916
2025
Q1
$4.75K Buy
+1,779
New +$5.53K ﹤0.01% 4087
2014
Q2
– Sell
-21
Closed -$536K – 3802
2014
Q1
$536K Buy
21
+6
+40% +$147K ﹤0.01% 1364
2013
Q4
$266K Buy
15
+2
+15% +$35.1K ﹤0.01% 1730
2013
Q3
$262K Buy
+13
New +$269K ﹤0.01% 1710

Other funds holding ACHV

PNC Financial Services Group's ACHV Position: Q4 2025 in Review

PNC Financial Services Group sold out of Achieve Life Sciences (ACHV) in Q4 2025, closing a stake of 826 shares — an estimated $2.6K sold.

PNC Financial Services Group first reported a position in ACHV in Q3 2013 and held it in 6 quarters. The position peaked at $536K in Q1 2014. 77 funds tracked by Wall St. Rank hold ACHV as of Q4 2025.

  • PNC Financial Services Group reported no remaining Achieve Life Sciences position as of Q4 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 826 Achieve Life Sciences shares in Q4 2025, an estimated $2.6K.
  • PNC Financial Services Group first reported a position in Achieve Life Sciences in Q3 2013 and held it in 6 quarters.
  • PNC Financial Services Group's Achieve Life Sciences position peaked at $536K in Q1 2014.
  • 77 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2025.

Based on PNC Financial Services Group's 13F filing for Q4 2025, filed 6 Feb 2026.